OpenLobby.EU
Explore

Carl Zeiss AG

CZ

Carl Zeiss AG develops and manufactures optical, precision mechanical, and optoelectronic products.

Lobbying Activity

Zeiss urges EU to include metrology in Advanced Materials Act

13 Jan 2026
Topic — This consultation seeks measures to strengthen Europe's research and production of advanced materials.
Message — Zeiss proposes integrating measurement technology into funded pilot lines and providing long-term support for shared research infrastructure. They also recommend using vouchers to help small companies access advanced quality control tools.123
Why — This ensures Zeiss remains the primary domestic supplier for essential material characterization tools.4
Impact — Foreign technology manufacturers could lose market share as the EU focuses on local supply.5
Read full response

Meeting with Olivér Várhelyi (Commissioner) and

18 Nov 2025 · Medical device review

Meeting with Estelle Goeger (Cabinet of Executive Vice-President Stéphane Séjourné) and Bundesverband der Deutschen Industrie e.V. and

4 Nov 2025 · Overview of the Commission's Single Market Strategy.

Meeting with Paul Speight (Head of Unit Environment) and KARL STORZ SE Co. KG

20 Oct 2025 · PFAS restriction

Meeting with Olivér Várhelyi (Commissioner) and

14 Oct 2025 · Competitiveness of the EU medical devices sector

Meeting with Dārta Tentere (Cabinet of Commissioner Maroš Šefčovič)

2 Oct 2025 · latest developments in the EU-US relations

Zeiss urges practical CBAM rules for complex downstream supply chains

20 Aug 2025
Topic — Expanding the carbon border adjustment mechanism to downstream products and anti-circumvention measures.
Message — Zeiss calls for a balanced framework that recognizes the realities of downstream supply chains. They emphasize the need for clear reporting requirements to avoid excessive administrative burdens.12
Why — A simplified framework would protect their global production networks and prevent high administrative overhead.3
Impact — European consumers could face higher prices if the regulation fails to protect the competitiveness of downstream industries.4
Read full response

Meeting with Matthias Ecke (Member of the European Parliament)

12 Aug 2025 · Optik / Mikroelektronik

Meeting with Dārta Tentere (Cabinet of Commissioner Maroš Šefčovič)

18 Jun 2025 · Economic security

Meeting with Maroš Šefčovič (Commissioner) and

26 May 2025 · Global trade developments and semiconductor sector

Meeting with Andrea Wechsler (Member of the European Parliament)

26 May 2025 · EU Industry policy

Meeting with Alexandra Geese (Member of the European Parliament) and Deutsche Telekom and

29 Apr 2025 · Event: DACH-Tech

Meeting with Andrea Wechsler (Member of the European Parliament) and ENGIE and Stegra (formerly H2GS AB)

19 Mar 2025 · EU Energy and industry policy

Meeting with Raphaël Glucksmann (Member of the European Parliament, Rapporteur)

6 Mar 2025 · Foreign Investments Screening Regulation

Response to Unique Device Identifiers for spectacle frames, spectacle lenses and ready-made reading spectacles

26 Feb 2025

Carl Zeiss Vision International GmbH, manufacturer of spectacles lenses, a subsidiary of Carl Zeiss AG, provides the following comments to the draft of Delegation Act Document (Document number Ares(2025)725943) amending Regulation (EU) 2017/745 of the European Parliament and of the Council, as regards the assignment of Unique Device Identifiers for spectacle frames, spectacle lenses and ready-to-wear reading spectacles, published for public consultation the 31st of January 2025 (hereinafter Draft ). Although the provided Draft contains the information of the Master UDI (MUDI) assignment and implementation timelines, it does not address the implication that this act will have on the registration of highly individualized devices i n EUDAMED. According to MDCG 2021-09 MDCG Position Paper on the Implementation of UDI requirements for contact lenses, spectacle frames, spectacle lenses & ready readers registration of devices starts to apply 24 months after the date of publication of the notice referred to in Article 34(3) MDR. Before this time, or until specific UDI assignment solutions are finalized, manufacturers of the abovementioned products are instructed not to use on a voluntary basis, the UDI/Device registration module of EUDAMED, to register devices and UDI related information as established in Part A and B of Annex VI MDR. In November 2024 the document Gradual roll out of EUDAMED was published on the Guidance - MDCG endorsed documents and other guidance web page, addressing the changes introduced by the amendment of the MDR and of the IVDR through Regulation (EU) 2024/1860 (hereinafter Guidance). According to Q7 of the Guidance the obligations and requirements laid down in Article 29 MDR and Article 26 IVDR regarding the registration of devices and systems and procedure packs in the EUDAMED UDI/DEV module will become applicable 6 months after the publication in the OJEU of the notice confirming its functionality. According to the Updated Timeline - Current planning for gradual roll out and modules functionality view published in July 2024 it is expected the UDI/Devices module becomes mandatory from Q1 2026. Meanwhile according to the Draft, the Delegation Act Document shall apply 3 years after the date of entry into force. That means that most probably the MUDI solution wont be ready and implemented by the industry when the UDI/Device module becomes mandatory but the obligation to register device may still apply. Furthermore, it is not clear how to proceed with highly individualized devices that are not specifically mentioned in the Guidance and it is left unclear if the earlier limitation from MDCG 2021-09 remains valid also for mandatory use of UDI/Device module with the Draft . Carl Zeiss Vision International GmbH kindly asks the European Commission and related MDCG Working group to clarify the EUDAMED timelines and obligations for highly individualized devices in the delegated act or relevant MDCG document.
Read full response

Meeting with Andreas Schwarz (Cabinet of Commissioner Ekaterina Zaharieva), Ann-Sofie Ronnlund (Cabinet of Commissioner Ekaterina Zaharieva)

30 Jan 2025 · Exchange of views on EU research and innovation framework programme Horizon Europe

Meeting with Michael Hager (Cabinet of Commissioner Valdis Dombrovskis)

30 Jan 2025 · Exchange of views on US-EU relationship

Meeting with Werner Stengg (Cabinet of Executive Vice-President Henna Virkkunen)

30 Jan 2025 · Presentation of company

Meeting with Pierre Chastanet (Head of Unit Communications Networks, Content and Technology)

30 Jan 2025 · Equipment for semiconductor manufacturing, competitiveness of EU semiconductor industry and economic security in the semiconductor sector

Meeting with Damien Levie (Head of Unit Trade)

29 Jan 2025 · Introductory meeting

Meeting with Kristin Schreiber (Director Internal Market, Industry, Entrepreneurship and SMEs)

29 Jan 2025 · PFAS restriction

Meeting with Matthias Ecke (Member of the European Parliament)

10 Dec 2024 · Industrie- und Innovationspolitik

Carl Zeiss AG Urges Streamlined Carbon Border Tax Authorizations

25 Nov 2024
Topic — This consultation defines authorization procedures for businesses reporting carbon costs on imported goods.
Message — The company requests automatic authorization if deadlines lapse and a weight-based exemption. They argue mandatory reviews for every change create enormous effort for companies.123
Why — Reduced effort and discretionary enforcement would lower compliance costs and administrative burdens.4
Impact — Climate transparency decreases if small imports are excluded from the carbon reporting system.5
Read full response

Meeting with Andreas Glück (Member of the European Parliament) and Bayer AG

21 Nov 2024 · Environmental Policy

Meeting with Marion Walsmann (Member of the European Parliament)

21 Nov 2024 · Vorstellung der Arbeit der CZ AG, aktuelle europapolitische Themen

Response to Enhancing research security in Europe

28 Dec 2023

ZEISS is an internationally leading technology enterprise operating in the optics and optoelectronics industries. As a company wholly owned by a foundation, ZEISS is rooted in and committed to responsibility in all its activities. As the pioneer of scientific optics, we continue to challenge the limits of human imagination. As a globally active company, we would like to submit the following suggestions regarding the proposal: 1. We agree with the overall objective(s) of the proposal. However, any (legislative) action should take into account the specifics of industrial research (including research that is carried out with partners from academia, research institutes, or others). In this context, any additional red tape in publicly (co-)funded projects should be avoided in order to maintain the attractiveness for companies to join. 2. Any (legislative) action should take into account the global character of large-scale (private-sector) corporations. Intra-company activities, including cross-border joint research efforts, should by no means be restricted. 3. Regarding additional security measures, any approach should be risk-based, thus assessing both the risk(s) of research projects (incl. measures to be taken as in the area of information sharing) and (ex ante) project partners.
Read full response

Meeting with Christiane Canenbley (Cabinet of Vice-President Věra Jourová)

11 Oct 2023 · Competitiveness of EU industry

Meeting with Virginijus Sinkevičius (Commissioner) and

4 Jul 2023 · To discuss with PFAS producers and users on the proposal for a REACH restriction on PFAS.

Meeting with Viola Von Cramon-Taubadel (Member of the European Parliament)

30 Jun 2023 · company visit

Meeting with Andreas Glück (Member of the European Parliament)

14 Jun 2023 · PFAS